{
  "id": "OPM-2025-0004-21258",
  "title": "Comment from Tony Bui",
  "category": "Agency",
  "analysis": {
    "stance": "Against",
    "themes": [
      "Politicization concerns",
      "Institutional knowledge loss"
    ],
    "key_quote": "I strongly oppose the proposed rule establishing a new \u201cSchedule Policy/Career\u201d designation, as this greatly weakens American leadership in health science.",
    "rationale": "The comment explicitly opposes the proposed rule and highlights concerns about politicization and the potential loss of stability and independence in federal scientific agencies, which aligns with themes opposing the rule."
  },
  "occurrence_number": 1,
  "duplicate_of": ""
}